Log In
Thursday 24th May 2018

NICE kidney cancer drug decision

26th August 2009

The National Institute for Clinical Excellence (NICE) has said doctors should not prescribe four kidney cancer drugs to new patients.

Although the Welsh health minister Edwina Hart had informed 22 health boards that they could give Avastin, Torisel, Sutent and Nexavar to patients, NICE said they were not "cost effective". A Welsh Assembly Government spokesperson said Ms Hart "expects clinicians in Wales to follow NICE recommendations for the use of these drugs now that the final guidance has been published".

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018